Our findings improve the understanding of the mechanisms of SARS-CoV-2 invasion in the CNS and suggest that blocking the SARS-CoV-2 envelope protein could be an important therapeutic strategy for the neurological complications of COVID-19 patients. Here, ERVW-1 is linked to COVID-19.